The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index; 11 of the 24 sources its claims cite were checked for support.
Reduction in community-onset methicillin-resistant Staphylococcus aureus rates in an urban Canadian hospital setting
Open accessAbstract
Between 2003 and 2011, episodes of emergency department MRSA bacteraemia and wounds were extracted from the laboratory database at two hospitals in Vancouver. ED MRSA bacteraemias peaked in 2005 at 7.8/10,000 ED visits, declining to 3.3/10,000 ED visits by 2011 (p<=0.03). MRSA wound rates peaked at 82.2 cases/10,000 ED visits in 2007, declining significantly to 34.3 cases/10,000 ED visits in 2011 (p=0.04).
Overview
CoChat Summary
TL;DR
This retrospective laboratory review found that community-onset MRSA presenting to two Vancouver emergency departments peaked in the mid-2000s and then declined significantly through 2011. The authors suggest the pattern is consistent with a broader change in CO-MRSA epidemiology in certain North American cities.
Key findings
- ED MRSA bacteraemia peaked in 2005 at 7·8/10,000 ED visits and fell to 3·3/10,000 in 2011 (r = −0·72, P = 0·03 for trend).
- ED MRSA wound isolates peaked in 2007 at 82·2/10,000 ED visits and declined to 34·3/10,000 in 2011 (r = −0·90, P = 0·04 for trend).
- Among ED wounds, TMP-SMX-susceptible MRSA rates fell from 79·5/10,000 in 2007 to 43·0 in 2009 and 32·4 in 2011 (P < 0·01 for trend), while the proportion of wound isolates susceptible to TMP-SMX did not change significantly (96·8% in 2007 vs. 95·5% in 2009 vs. 94·3% in 2011).
- PVL PCR testing of available ED bacteraemia isolates found 40/47 (85·1%) positive in 2007 and 20/29 (69·0%) positive in 2008.
Methods
- Retrospective review of the Providence Health Care laboratory database at two Vancouver acute-care hospitals (a 435-bed tertiary hospital and a 101-bed community hospital) from 1 January 2003 to 31 December 2011.
- Included the first ED MRSA isolate per patient annually for bacteraemia and deep/superficial wound cultures; ED isolates were assumed to be community-onset because patients acquired infection within 72 h of admission.
- Calculated annual rates per 10,000 ED visits and used Spearman rank correlation to assess trends; available 2007–2008 bacteraemia isolates underwent PVL PCR testing.
Limitations
- The paper states that laboratory-based data may underestimate true MRSA rates because cases depended on physicians collecting wound swabs or blood cultures, though diagnostic practices did not change markedly over the study period.
- The paper states that assuming all ED isolates were CO-MRSA may have underestimated CO-MRSA rates, that prior hospitalization could not be ruled out, and that larger molecular testing is needed to confirm whether declines reflect decreasing USA300 prevalence.
- Evident from the text: this is an observational, single-health-system study without full molecular typing of all isolates, so it cannot establish the cause of the decline.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
9 Valid · 0 Not valid · 8 Not checked · 23 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The epidemiology of MRSA within inner-city populations in Vancouver, Canada has mirrored that of San Francisco.”
What the sources say
- Partly supportedcites [4] 4. Al-Rawahi GN, et al . Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later. Journal of clinical microbiology 2008; 46 : 477 -479. sourceExperimental — accuracy not yet measured
The Discussion reports a change in MRSA among injection drug users in Vancouver’s downtown east side, with USA-300 replacing USA-500 as the predominant strain. The paper mentions San Francisco in a reference on infections among injection drug users, but our copy does not compare the two cities’ epidemiology or say that Vancouver mirrored San Francisco. No page numbers are available in the indexed copy. (LLM, conf=0.78)
- Not matchedcites [5] 5. Hull M, et al . High prevalence of PVL positive community associated MRSA isolates from clinical isolates at Providence Health Care, Vancouver, BC. AMMI Canada -CACMID 2007 Annual Conference , Halifax, Nova Scotia, 2007.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Could not verifycites [6] 6. Lloyd-Smith E, et al . Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users. Epidemiology & Infection 2010; 138 : 713 -720. sourceExperimental — accuracy not yet measured
The Methods describe a US laboratory network, and the Discussion reports MRSA trends among US outpatients and inpatients (page numbers unavailable). Searches for Vancouver, San Francisco, and a comparison of inner-city populations found no passage addressing the claimed similarity. (LLM, conf=0.75)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The incidence of CO-MRSA bacteraemias decreased from 0·68/1000 veterans in care in 2006 to 0·21/1000 veterans in care in 2011 ( P <0·001).”
What the sources say
- Supportedcites [10] 10. Stenehjem E, Stafford C, Rimland D. Reduction of methicillin-resistant Staphylococcus aureus infection among veterans in Atlanta. Infection Control & Hospital Epidemiology 2013; 34 : 62 -68. source
The Results (CO MRSA) give the same decline, denominator, years, and P value for community-onset MRSA-positive blood cultures. The paper counts positive blood cultures regardless of the primary site of infection; its years are fiscal years. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By 2011, rates of ED bacteraemia declined signi fi cantly to 3·3/10000 ED visits ( P 4 0·03).”
- Also stated in: § SUMMARY · p. 2 · plain
“decreased to 3·3 cases/10000 ED visits in 2011 ( r = -0·72, P =0·03 for trend)”
plainn = 378 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § SUMMARY · p. 2 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“MRSA wound rates peaked at 82·2 cases/10000 ED visits in 2007”
- Also stated in: § SUMMARY · p. 3 · plain
“By 2007, the ED MRSApositive wound rates had peaked at 82·2 cases/10000 ED visits ( r =1·00, P <0·01 for trend)”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § SUMMARY · p. 3 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For ED wounds, rates of TMP-SMX susceptible MRSA isolates declined signi fi cantly from 79·5 cases/10000 ED visits in 2007 to 43·0 in 2009 to 32·4 cases/10000 ED visits in 2011 ( r =0·85, P <0·01 for trend).”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
14 more claims
Create a free account to see all 40 claims and every source verdict.
- Probably not a substantial claim. 13
- It may state two separate claims as one. 13
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ SUMMARY · p. 3
“For ED wounds, rates of TMP-SMX susceptible MRSA isolates declined signi fi cantly from 79·5 cases/10000 ED visits in 2007 to 43·0 in 2009 to 32·4 cases/10000 ED visits in 2011 ( r =0·85, P <0·01 for trend).”
§ SUMMARY · p. 2
“The Spearman rank correlation test and coef fi cient ( r ) was used to determine the strength as well as the direction of the association between infection rates and calendar year.”
Citations
Cites
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Oliveira, D. C., Tomasz, A., & de Lencastre, H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00227-x · Cited by 494
Health Care–Associated Invasive MRSA Infections, 2005-2008
Kallen, A. J. (2010) · JAMA · doi:10.1001/jama.2010.1115 · Cited by 439
Chaos, Persistence, and Evolution of Strain Structure in Antigenically Diverse Infectious Agents
Gupta, S., Ferguson, N., & Anderson, R. (1998) · Science · doi:10.1126/science.280.5365.912 · Cited by 298
Hospital utilization and costs in a cohort of injection drug users.
(2001) · PubMed Central · Cited by 263
Landrum, M. L., Neumann, C., Cook, C., Chukwuma, U., Ellis, M. W., Hospenthal, D. R., & Murray, C. K. (2012) · JAMA · doi:10.1001/jama.2012.7139 · Cited by 228
Liu, C., Graber, C. J., Karr, M., Diep, B. A., Basuino, L., Schwartz, B. S., Enright, M. C., O’Hanlon, S. J., Thomas, J. C., Perdreau‐Remington, F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587893 · Cited by 205
Origins of Community Strains of Methicillin-Resistant Staphylococcus aureus
Charlebois, E. D., Perdreau-Remington, F., Kreiswirth, B., Bangsberg, D. R., Ciccarone, D., Diep, B. A., Ng, V. L., Chansky, K., Edlin, B., & Chambers, H. F. (2004) · Clinical Infectious Diseases · doi:10.1086/421090 · Cited by 174
(2009) · Emerging Infectious Diseases · doi:10.3201/eid1512.081341 · Cited by 102
Methicillin-resistant Staphylococcus aureus in HIV-infected patients
Hidrón, A., Moanna, A., Kempker, R. R., & Rimland, D. (2010) · Infection and Drug Resistance · doi:10.2147/idr.s7641 · Cited by 73
Cited by
Mitevska, E., Wong, B., Surewaard, B. G. J., & Jenne, C. N. (2021) · Pathogens · doi:10.3390/pathogens10040393 · Cited by 58
“…ON HospitalPatients Stenstrom et al., 2009 Prevalence: 54.8% of SSTI patients, 68% after 21 months 2003–2004 Vancouver, BC SSTI patients inED Wilmer et al., 2014 Prevalence (in wound isolates, per 10 000 ED visits): 2003: 12.0 2004: 23.0 2005: 40.1 2006: 76.7 2007: 82.2 2008: 68.2 2009:…”
InfluentialMendes, R. E., Watters, A. A., Rhomberg, P. R., Farrell, D. J., & Jones, R. N. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02047-15 · Cited by 20
Mendes, R. E., Deshpande, L. M., Costello, A. J., Farrell, D. J., Jones, R. N., & Flamm, R. K. (2015) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0307 · Cited by 10
Epidemiology of meticillin-resistant Staphylococcus aureus bloodstream infections in Alberta, Canada
Taylor, G., Bush, K. J., Leal, J. R., Henderson, E., Chui, L., & Louie, M. (2014) · Journal of Hospital Infection · doi:10.1016/j.jhin.2014.11.008 · Cited by 10
Metadata
- Authors
- WILMER, A., LLOYD-SMITH, E., ROMNEY, M. G., CHAMPAGNE, S., WONG, T., ZHANG, W., STENSTROM, R., & HULL, M. W.
- Affiliations
- University of British Columbia (CA)
- Providence Health Care (CA)
- St. Paul's Hospital (CA)
- Corresponding author
- HULL, M. W.
- Venue
- Epidemiology and Infection
- Publisher
- Cambridge University Press (CUP)
- Published
- 2013-06-28
- Volume
- 142
- Issue
- 3
- Pages
- 463-467
- ISSN
- 0950-2688 (ISSN-L)
- 1469-4409
- PMC
- PMC9151091
- OpenAlex
- W2152492527
- Cited by
- 4
- References
- 17
- Citations by year
- 2021: 1 · 2015: 2 · 2014: 1
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Epidemiology and Infection (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- methicillin-resistant Staphylococcus aureus, MRSA bacteremia, emergency department visits, hospital infection rates, Vancouver
- MeSH terms
- British Columbia, Emergency Service, Hospital, Female, Humans, Male, Staphylococcal Infections, Staphylococcal Skin Infections, Prevalence, Bacteremia, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction in community-onset methicillin-resistant Staphylococcus aureus rates in an urban Canadian hospital setting. https://app.cochat.ai/papers/10.1017/s0950268813001568
- The paper
- WILMER, A., LLOYD-SMITH, E., ROMNEY, M. G., CHAMPAGNE, S., WONG, T., ZHANG, W., STENSTROM, R., & HULL, M. W. (2014). Reduction in community-onset methicillin-resistant Staphylococcus aureus rates in an urban Canadian hospital setting. Epidemiology and Infection. https://doi.org/10.1017/s0950268813001568
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.